Phillip D. Carter, MBA

Duke Capital Partners, Duke Universitys official early-stage venture investment arm, provides capital and expertise to help Duke startups, and features one of Duke’s most innovative experiential learning opportunities for students. As one of the largest and oldest university investment entities of its kind, Duke Capital Partners consistently places among the top five in North America. Our mission is to support the global Duke entrepreneurial community with an angel investing platform and co-investment fund (the Duke Innovation Fund) that engage and leverage the unparalleled Duke network.

As a boutique consultancy specializing in product development and commercialization strategy, we help innovators and early-stage biotech and medtech companies overcome challenges that prevent promising healthcare solutions from reaching their full potential. The opportunity to catalyze these innovations is the fuel that drives our team at VectgenBio: ♦ We partner with founders, senior executives, and investors to increase company and asset value by embedding physician, patient, and payer needs throughout the development cycle. ♦ We measure success by accelerating the delivery of milestones/value-inflection points and enhancing product differentiation. ♦ We believe long-term partnerships provide leadership agility and drive strategic continuity. Please reach out to explore how we can help your team turn innovative ideas into impactful healthcare solutions.

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

Duke Capital Partners, Duke Universitys official early-stage venture investment arm, provides capital and expertise to help Duke startups, and features one of Duke’s most innovative experiential learning opportunities for students. As one of the largest and oldest university investment entities of its kind, Duke Capital Partners consistently places among the top five in North America. Our mission is to support the global Duke entrepreneurial community with an angel investing platform and co-investment fund (the Duke Innovation Fund) that engage and leverage the unparalleled Duke network.

As a boutique consultancy specializing in product development and commercialization strategy, we help innovators and early-stage biotech and medtech companies overcome challenges that prevent promising healthcare solutions from reaching their full potential. The opportunity to catalyze these innovations is the fuel that drives our team at VectgenBio: ♦ We partner with founders, senior executives, and investors to increase company and asset value by embedding physician, patient, and payer needs throughout the development cycle. ♦ We measure success by accelerating the delivery of milestones/value-inflection points and enhancing product differentiation. ♦ We believe long-term partnerships provide leadership agility and drive strategic continuity. Please reach out to explore how we can help your team turn innovative ideas into impactful healthcare solutions.

First Flight (FFVC) is a science and technology incubator located in the heart of Research Triangle Park. Established in 1991 to serve the initial needs of entrepreneurs and early stage companies. FFVC strives to produce companies that graduate from the facility as financially viable and freestanding businesses. These incubator graduates migrate into the mainstream of the business community, creating jobs and commercializing important new technologies that contribute to a stronger North Carolina economy. We have more than 30 years experience in successfully launching new businesses in North Carolina. This success lies in First Flight’s turnkey approach—the ability to enable tenant businesses to reduce both their initial capitalization requirements and their annual operation costs by providing affordable space with flexible leases, shared business services, technology support services, and management guidance and counseling. FFVC offers 25,000 square feet of leasable office and laboratory space for up to 40 emerging technology companies.

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia